Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing ...
DeepSeek-R1 charts a new path for AI through explaining its own reasoning process. Why does this matter and how will it ...
Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of ...
A-listers including Brad Pitt and Tom Hanks have addressed scams involving their identity that have turned people’s lives ...
The future of oncology lies in people-centered care, prioritizing patient needs and leveraging technology to improve cancer ...
Cervical cancer screening traditionally relies on the Pap smear and HPV-DNA tests. While effective, these methods are fraught with challenges, including variability in human interpretation, false ...
A Spanish artificial intelligence startup called Quibim S.L. said today it has closed on a $50 million Series A funding round ...
Modella AI, a pioneer in generative and agentic artificial intelligence for biomedicine, is proud to announce that its ...
The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback